CEP55 is an oncoprotein that demonstrated upregulation in cancerous tissues in multiple human tumors, and this upregulation was positively correlated with tumor stage, grade, metastasis, and poor clinical outcomes. This evidence concerns the gene CEP55 and neoplasm.